S

Sophiris Bio Inc.

4 employees

Sophiris Bio is a biopharmaceutical company that develops topsalysin for the treatment of urological diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Biopharma
Clinical Trials

Date founded

2002

Funding rounds raised

Total raised

$35M

from 3 investors over 3 rounds

S

Sophiris Bio Inc. raised $2M on May 17, 2014

Investors: Aspire Capital Partners, LLC

S

Sophiris Bio Inc. raised undisclosed on January 1, 2013

Investors: Sofinnova Ventures, Russia technology fund

S

Sophiris Bio Inc. raised $35M on September 29, 2010

Investors: Warburg Pincus LLC

FAQ